CBIO financial statements and SEC filings
CBIO annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $10.84M | -$152.63M | -$133.45M | 10-K |
| 2024-12-31 | – | -$40.04M | -$37.88M | 10-K |
| 2023-12-31 | $10.00K | -$39.28M | -$36.90M | 10-K |
| 2022-12-31 | $75.00K | -$47.40M | -$46.69M | 10-K |
| 2021-12-31 | $1.16M | -$63.45M | -$63.43M | 10-K |
| 2020-12-31 | $10.16M | -$51.51M | -$51.03M | 10-K |
CBIO annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $240.29M | $37.28M | $203.01M | 10-Q |
| 2024-12-31 | $35.62M | $47.10M | -$15.48M | 10-K |
| 2023-12-31 | $45.32M | $6.90M | $38.41M | 10-K |
| 2022-12-31 | $51.81M | $8.88M | $42.93M | 10-K |
| 2021-12-31 | $94.35M | $12.74M | $81.60M | 10-K |
| 2020-12-31 | $142.83M | $14.61M | $128.22M | 10-K |
CBIO annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | -$71.53M | -$919.00K | $322.98M | 10-K |
| 2024-12-31 | -$31.10M | -$9.97K | $5.40K | 10-K |
| 2023-12-31 | -$34.88M | -$21.39K | $28.82M | 10-K |
| 2022-12-31 | -$46.46M | -$84.19K | $4.16M | 10-K |
| 2021-12-31 | -$57.49M | -$14.94K | $10.72M | 10-K |
| 2020-12-31 | -$39.24M | -$68.51K | $18.14M | 10-K |